CWEB TOR Week ended 07 Aug 2026

Weekly Investor Report

Charlotte's Web Holdings, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data
Latest close 0.35 CAD
9.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -48.4% below the Trend Line and sits at 19.7% of its 52-week range. The latest completed week returned 9.4%, after a -25.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 45/100.

Setup score 23 out of 100
Latest Close 0.35 CAD 7 Aug 2026
1W Return 9.4% latest completed week
4W Return -25.5% short-term follow-through
12W Return -40.7% quarterly tape
Trend Breadth 67.3% 35 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Latest weekly return ranks in the strongest part of its sector group.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 33.70% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 9.4% Latest completed week; four-week move -25.5%. Indicator stack 37/29 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 33.70% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 45/100 3 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -48.4% below the Trend Line and sits at 19.7% of its 52-week range. The latest completed week returned 9.4%, after a -25.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0912-week average 0.35

12-week confirmation

Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.09Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -25.5% over four weeks, -40.7% over 12 weeks, and 150.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W9.4%
4W-25.5%
12W-40.7%
26W-50.7%
52W150.0%
Active trend streak0 weeks
Active weeks in one year35
Trend breadth67.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.25Latest activity-pressure read.
Pressure change12.6%Four-week change in activity pressure.
Leadership-34.79Latest relative-leadership reading.
RS change-363.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 70% Model confidence 65%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength61/100Blend of value, momentum, and quality. Underlying universe rank 40; rank 1 is best.
Value54/100Relative valuation strength. Underlying universe rank 47; rank 1 is best.
Quality56/100Profitability and accounting quality. Underlying universe rank 45; rank 1 is best.
Momentum57/100Medium-term price momentum. Underlying universe rank 44; rank 1 is best.
Growth57/100Revenue and earnings growth. Underlying universe rank 44; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
1.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-9.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
42.4%
Gross profit retained from each unit of revenue.
Operating margin
-39.4%
Operating profit retained from revenue.
Free-cash-flow margin
-29.1%
Free cash flow generated from revenue.
Return on invested capital
-32.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
0.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-4.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment45/100

Weighted news tone is neutral across 3 relevant articles.

0 positive · 2 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-73.7%Distance below the 52-week high.
13-week volatility13.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2613 weeks finished lower.
Best week+47.9%Week of 13 Feb.
Worst week-31.9%Week of 17 Jul.
Latest week+9.4%Week of 7 Aug.

Shape of recent returns

Strong gains10
Modest gains1
Flat weeks2
Modest losses1
Sharp losses12
Recent vol13.7%13-week weekly-return volatility.
Base vol23.4%52-week weekly-return volatility.
Up/down split25/21Count of positive and negative weeks in the 52-week window.
Average skew20.2% / -13.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 1/12, activity pressure 0/12, relative leadership 4/12.

Activity pressure 0.09; No reversal markers Next-Week ExpectancyNegative 33.70%

Next-week expectancy is negative with a 33.70% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors56/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 46; Small Cap Core rank 48 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment45/100

Weighted news tone is neutral across 3 relevant articles.

Stocks in play: Charlotte's Web Holdings, Inc. Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20260.35 CAD9.4%0.68 CAD0.31 CAD-1.25-34.79334.8KOff
31 Jul 20260.32 CAD-5.9%0.68 CAD0.31 CAD-1.30-38.06259.6KOff
24 Jul 20260.34 CAD6.3%0.69 CAD0.31 CAD-1.28-34.05798.5KOff
17 Jul 20260.32 CAD-31.9%0.70 CAD0.31 CAD-1.35-37.341.1MOff
10 Jul 20260.47 CAD6.8%0.70 CAD0.31 CAD-1.42-7.5076.8KOff
3 Jul 20260.44 CAD0.0%0.69 CAD0.31 CAD-1.41-12.275.0KOff
26 Jun 20260.44 CAD10.0%0.68 CAD0.31 CAD-1.37-10.6210.7KOff
19 Jun 20260.40 CAD-25.9%0.67 CAD0.31 CAD-1.26-17.86203.3KOff
12 Jun 20260.54 CAD-5.3%0.66 CAD0.30 CAD-1.2212.0033.2KOff
5 Jun 20260.57 CAD-14.9%0.64 CAD0.30 CAD-1.1921.82170.6KOff
29 May 20260.67 CAD17.5%0.63 CAD0.30 CAD-1.1544.10520.9KOff
22 May 20260.57 CAD-3.4%0.62 CAD0.30 CAD-1.1126.18165.3KOn
15 May 20260.59 CAD-4.8%0.60 CAD0.30 CAD-0.7635.35306.3KOn
8 May 20260.62 CAD-13.9%0.59 CAD0.30 CAD-0.6143.88508.2KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context